Wolverine Trading, LLC Macrogenics Inc Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $5.55 $133,500 - $246,975	44,500 New	44,500 $146,000
Q3 2021 Nov 12, 2021	SELL	$19.74 - $28.7 $305,970 - $444,850	-15,500 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$20.49 - $35.63 $180,312 - $313,544	8,800 Added 131.34%	15,500 $414,000
Q1 2021 May 14, 2021	BUY	$18.99 - $33.2 $127,232 - $222,440	6,700 New	6,700 $208,000
Q4 2020 Feb 12, 2021	SELL	$19.41 - $26.0 $186,336 - $249,600	-9,600 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$24.69 - $31.6 $143,202 - $183,280	-5,800 Reduced 37.66%	9,600 $242,000
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $171,094 - $394,240	15,400 New	15,400 $277,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.